Proof of Usefulness Report

HQ Science Ltd.

Analysis completed on 3/7/2026

+10
Proof of Usefulness Score
You're In Business

The submission for HQ Science Ltd. presents a high-potential mission (personalized cancer diagnostics) but suffers severely from low-quality data and demonstrably false claims. The statement that 'most people have used my product' is objectively untrue for a specialized medical device, destroying credibility regarding traction. While the company appears to be a registered UK entity ('HQ SCIENCE LIMITED') with a legitimate website, the submission's claim of a 50,000 'marketcap' as revenue and the generic audience targeting ('everyone') indicate a lack of business maturity or a careless submission. The project lacks verifiable evidence of regulatory approval, adoption, or commercial viability required for a higher score.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+40
Audience Reach Impact+10
Technical Innovation+30
Evidence Of Traction+0
Market Timing Relevance+50
Functional Completeness+10
Subtotal+11
Usefulness Multiplierx0.91
Final Score+10

Project Details

Project URL
Description
We have set out to revolutionise the field of personalised cancer diagnostics by providing AI-driven point-of-care solutions to improve clinical outcomes in cancer patients. Our vision extends beyond this, as we aim to unlock point-of-need personalised diagnostics solutions for medical professionals and individuals alike within various medical domains.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline